Markets:

Overview

News

Currencies

International

Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

11.64 -0.12 (-1.02%)

Streaming Delayed Price Updated: 11:50 AM EST, Feb 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

5 Stocks To Watch For January 12, 2022 ↗

January 12, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects Shaw Communications Inc. (NYSE: SJR) to report quarterly earnings at $0.29 per share on revenue...

Via Benzinga

Here Are Answers for Shareholders After General Electric Breaks Up ↗

November 10, 2021

Larry Culp was hired to save GE in 2018, but finally decided to break it up in order to unlock what's left of its value, especially in the healthcare unit.

Via InvestorPlace

Integra LifeSciences Stock Rises On Street-Beating Q3 Earnings, Raises FY21 EPS Guidance ↗

November 02, 2021

Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares got a boost as Q3 adjusted EPS of $0.86 topped the consensus forecast of $0.72. Revenues increased...

Via Benzinga

Integra LifeSciences Holdings Corporation (IART) Q3 2021 Earnings Call Transcript ↗

November 02, 2021

IART earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗

November 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 ↗

December 17, 2021

Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ:

Via Benzinga

The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal ↗

July 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

April 23, 2021

On Friday morning, 152 companies hit new 52-week highs. Things to Consider: The largest company by market cap to hit a new 52-week high was ASML Holding (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

5 Stocks Insiders Are Selling ↗

October 28, 2021

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021 ↗

September 15, 2021

Upgrades For Alcoa Corp (NYSE:

Via Benzinga

Notable Integra Lifesciences Insider Trades $11.46 Million In Company Stock ↗

September 08, 2021

Peter Arduini, President And Ceo at Integra Lifesciences (NASDAQ:IART), made a large buy and sell of company shares on September 3, according to a new SEC filing. What Happened: A...

Via Benzinga

Topics Regulatory Compliance

Integra's Update On FY21 Acell Revenues To Weigh On Stock, Piper Sandler Says ↗

July 28, 2021

Piper Sandler has

Via Benzinga

Integra LifeSciences Holdings Corporation (IART) Q2 2021 Earnings Call Transcript ↗

July 28, 2021

IART earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Integra Lifesciences Q2 Earnings ↗

July 28, 2021

Shares of Integra Lifesciences (NASDAQ:IART) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share increased 139.39% over the past year...

Via Benzinga

Integra Lifesciences Holdings Corp (IART) Q1 2021 Earnings Call Transcript ↗

April 28, 2021

IART earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Integra Lifesciences: Q1 Earnings Insights ↗

April 28, 2021

Shares of Integra Lifesciences (NASDAQ:IART) rose 1.5% in pre-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 43.75%...

Via Benzinga

The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More ↗

July 25, 2021

Biotech stocks rebounded in the week ended July 23, thanks to the broader market strength. The sector also benefitted from the optimism that was set in motion by the solid start...

Via Benzinga

The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗

July 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs ↗

April 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs ↗

April 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...

Via Benzinga

The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue ↗

April 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.